We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
+9.15%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$104M
AUM Growth
–
Cap. Flow
+$97.1M
Cap. Flow
% of AUM
93.05%
Top 10 Holdings %
Top 10 Hldgs %
4.92%
Holding
1,330
New
1,330
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRC Group Holdings
RILY
|
+$733K |
| 2 |
iHeartMedia
IHRT
|
+$672K |
| 3 |
Taysha Gene Therapies
TSHA
|
+$581K |
| 4 |
NextDecade
NEXT
|
+$540K |
| 5 |
Appian
APPN
|
+$466K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.72% |
| 2 | Technology | 15.99% |
| 3 | Industrials | 14.77% |
| 4 | Financials | 13.46% |
| 5 | Consumer Discretionary | 12.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
First Busey Corp
BUSE
$2.52B
| $40.4K | 0.04% |
+1,626
| New | +$34.8K |
|
827
Blackbaud
BLKB
$1.5B
| $40.2K | 0.04% |
+464
| New | +$35.1K |
|
828
Coty
COTY
$2.33B
| $40.2K | 0.04% |
+3,233
| New | +$34.9K |
|
829
Marriott Vacations Worldwide
VAC
$3.24B
| $40.1K | 0.04% |
+472
| New | +$40.3K |
|
830
Jabil
JBL
$32.8B
| $40K | 0.04% |
+314
| New | +$40K |
|
831
Global Industrial
GIC
$1.34B
| $39.8K | 0.04% |
+1,025
| New | +$36.5K |
|
|
THR
832
DELISTED
Thermon Group Holdings
THR
| $39.6K | 0.04% |
+1,215
| New | +$36.2K |
|
833
Anavex Life Sciences
AVXL
$222M
| $39.5K | 0.04% |
+4,247
| New | +$29.2K |
|
834
D.R. Horton
DHI
$41B
| $39.5K | 0.04% |
+260
| New | +$32K |
|
835
Archrock
AROC
$6.33B
| $39.4K | 0.04% |
+2,557
| New | +$35.6K |
|
836
Cincinnati Financial
CINF
$28.3B
| $39K | 0.04% |
+377
| New | +$38.3K |
|
837
FirstCash
FCFS
$8.55B
| $38.9K | 0.04% |
+359
| New | +$38.8K |
|
838
STAAR Surgical
STAA
$1.16B
| $38.8K | 0.04% |
+1,244
| New | +$44.7K |
|
839
FIVE9
FIVN
$1.77B
| $38.7K | 0.04% |
+492
| New | +$34.3K |
|
840
Neurocrine Biosciences
NBIX
$17.7B
| $38.6K | 0.04% |
+293
| New | +$33.7K |
|
841
Apogee Therapeutics
APGE
$10.2B
| $38.6K | 0.04% |
+1,380
| New | +$27.7K |
|
842
Cadre Holdings
CDRE
$1.32B
| $38.5K | 0.04% |
+1,170
| New | +$35.4K |
|
|
NVRO
843
DELISTED
NEVRO CORP.
NVRO
| $38.5K | 0.04% |
+1,787
| New | +$31.9K |
|
844
Miller Industries
MLR
$586M
| $38.1K | 0.04% |
+901
| New | +$35.5K |
|
845
Insperity
NSP
$1.85B
| $38.1K | 0.04% |
+325
| New | +$35.1K |
|
846
Crescent Capital BDC
CCAP
$399M
| $38K | 0.04% |
+2,188
| New | +$36.4K |
|
847
Sinclair Inc
SBGI
$974M
| $38K | 0.04% |
+2,916
| New | +$35.8K |
|
|
CVGW
848
DELISTED
Calavo Growers
CVGW
| $37.8K | 0.04% |
+1,286
| New | +$33.1K |
|
849
Prospect Capital
PSEC
$1.06B
| $37.8K | 0.04% |
+6,310
| New | +$36.3K |
|
850
Apogee Enterprises
APOG
$850M
| $37.8K | 0.04% |
+707
| New | +$32.9K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
KFSC
YCM
SC
EntryPoint Capital's Q4 2023 Portfolio in Review
Q4 2023 is the first quarter with a 13F filing on record for EntryPoint Capital, which disclosed 1,330 positions worth $104M. Its ten largest holdings account for 4.9% of the portfolio.
Its largest position is BRC Group Holdings: 25,051 shares worth $526K.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, followed by Technology and Industrials.
- EntryPoint Capital's largest Q4 2023 buy was BRC Group Holdings: 25,051 shares worth $526K.
- EntryPoint Capital's ten largest holdings make up 4.9% of its $104M portfolio in Q4 2023.
- EntryPoint Capital disclosed 1,330 positions in Q4 2023, its first 13F filing on record.
Based on EntryPoint Capital's 13F filing for Q4 2023, filed 14 Feb 2024.